Resultados de la búsqueda 331-340 of 8878 for Lithium toxicity

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...